Cartiva
Acquisition in 2018
Cartiva, Inc. is a medical device company focused on developing innovative solutions for orthopedic surgeons and patients suffering from osteoarthritis and cartilage damage. Founded in 2011 and headquartered in Alpharetta, Georgia, Cartiva markets the Cartiva Synthetic Cartilage Implant, which is designed to mimic natural cartilage and alleviate pain by restoring the joint structure in affected areas, including the first metatarsophalangeal joint, ankle, and knee. Additionally, Cartiva offers the ProxiFuse Hammertoe Correction System for the fixation of osteotomies and reconstruction of lesser toes. The company sells its products through various distributors in regions such as Brazil, Canada, and the United Kingdom. With a management team and board composed of experts in orthopedics, Cartiva aims to enhance patient outcomes through effective treatments for cartilage injuries and related discomfort. As of October 2018, Cartiva operates as a subsidiary of a larger medical group.
Imascap
Acquisition in 2017
Imascap is a developer of advanced software specifically designed for the preoperative planning of shoulder replacement surgery. Its innovative software system empowers orthopedic surgeons to independently plan procedures using only CT scan image data of the patient. This capability allows for the automatic creation of a patient-specific surgical guide, enabling precise implantation of prostheses in accordance with the planned position. The software also supports three-dimensional image reproduction and real-time navigation through optical and infrared localization, contributing to reduced surgery duration and minimizing the risks associated with artificial shoulder insertions. Developed in collaboration with leading experts in shoulder surgery, Imascap's technology aims to enhance the effectiveness of orthopedic procedures and foster the advancement of new prosthetic designs tailored to individual patient anatomies.
OrthoPro
Acquisition in 2014
OrthoPro, Inc. is an orthopaedic manufacturers representation organization in North Carolina carrying one product line, BREG, Inc. BREG is a premier manufacturer of many orthopaedic and sports medicine supplies including bracing, cold therapy, and pain management products. Since that day, we have grown significantly and now represent multiple product lines and have expanded our sales force and distribution rights throughout VA, NC, and SC.
Solana Surgical
Acquisition in 2014
Solana Surgical is a global orthopedic company established in 2011 by former executives from an extremity-focused firm. The company specializes in the manufacture and distribution of orthopedic products tailored for extremity surgery, particularly concerning the bones of the foot and ankle. With a commitment to innovation and quality, Solana Surgical aims to establish itself as a leading provider in the orthopedic market, focusing on enhancing surgical outcomes in extremity procedures.
Biotech International
Acquisition in 2013
Biotech International is a French company established in 1987, specializing in the design, manufacture, and distribution of dental and orthopedic implants. The company adheres to stringent European standards in manufacturing, traceability, safety, labeling, and packaging. Biotech International's products are developed through close collaboration with surgeons, lab technicians, and biomaterials specialists, as well as its own research and development center. This collaborative approach ensures that their offerings reflect a commitment to quality and usability. With a strong international presence, Biotech International effectively addresses the diverse needs and expectations of healthcare professionals across various cultures and backgrounds.
Biomimetic Therapeutics
Acquisition in 2012
BioMimetic Therapeutics is a biotechnology company based in Franklin, Tennessee, founded in 1999. The company focuses on the development of biologically active drug-device combination products designed to stimulate the body's natural tissue regenerative processes. Its product portfolio includes Augment Injectable and Augment Rotator Cuff, which target various orthopedic and sports medicine conditions. These products are utilized for treating foot and ankle fusions, facilitating wrist fracture healing, and addressing surgical interventions for rotator cuff tears. Additionally, BioMimetic Therapeutics offers the Augment Tendinopathy Injection, aimed at managing injuries resulting from tendon overuse. The company is dedicated to advancing solutions for the healing of injuries and diseases affecting the skeleton and associated tissues.
Cremascoli Ortho
Acquisition in 2000
Cremascoli Ortho Group is manufacturer of artificial joint systems.